David A. Reis, Director at Genesis Healthcare, Inc. (GEN), sold 44,975 shares at $1.72 ($78K) on 2018-08-29, disclosed to the SEC on 2018-08-31.
Scheduled sale ($78k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.72 | 722 | $1K | 1.6% |
| 2 | $1.72 | 1,563 | $3K | 3.4% |
| 3 | $1.72 | 21,770 | $37K | 47.9% |
| 4 | $1.76 | 627 | $1K | 1.4% |
| 5 | $1.76 | 1,360 | $2K | 3.1% |
| 6 | $1.76 | 18,933 |
| $33K |
| 42.6% |
| Total | $1.74 avg | 44,975 | $78K | 100% |
| Filing → |
| GEN | SELL | 2018-11-15 | $53K | — | Filing → |
| GEN | SELL | 2018-11-13 | $73K | — | Filing → |
| GEN | SELL | 2018-11-09 | $92K | — | Filing → |